Sherief Abd-Elsalam to Sustained Virologic Response
This is a "connection" page, showing publications Sherief Abd-Elsalam has written about Sustained Virologic Response.
Connection Strength
0.674
-
Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection. Infect Disord Drug Targets. 2020; 20(3):389-395.
Score: 0.174
-
Hepatitis C Virus: Efficacy of New DAAs Regimens. Infect Disord Drug Targets. 2020; 20(2):143-149.
Score: 0.174
-
Sofosbuvir, Pegylated Interferon and Ribavirin in the Treatment of an Egyptian Cohort with Hepatitis C Virus Infection in Real-Life Clinical Practice. Infect Disord Drug Targets. 2019; 19(2):179-184.
Score: 0.163
-
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients with Chronic Hepatitis C: Real-world Results from 1716 Patients in Egypt. Endocr Metab Immune Disord Drug Targets. 2019; 19(7):1005-1011.
Score: 0.163